Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
sarcoplasmic reticulum | - |
Rattus norvegicus | 16529 | - |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
cardiac myocyte | - |
Rattus norvegicus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + H2O + Ca2+/cis | - |
Rattus norvegicus | ADP + phosphate + Ca2+/trans | - |
? | |
ATP + H2O + Ca2+/out | - |
Rattus norvegicus | ADP + phosphate + Ca2+/in | - |
? |
Synonyms | Comment | Organism |
---|---|---|
sarcoplasmic reticulum Ca2+ ATPase | - |
Rattus norvegicus |
SERCA2 | - |
Rattus norvegicus |
Organism | Comment | Expression |
---|---|---|
Rattus norvegicus | isoform SERCA2 downregulation (30-60%) occurs following infection of myocytes with adenovirus vectors carrying luciferase or isoform SERCA1 cDNA under control of nuclear factor of activated T cells (NFAT)-dependent promoters. Competitive engagement of the CN/NFAT pathway by endogenous genes involved in hypertrophy produces downregulation of SERCA2 | down |
Rattus norvegicus | in the presence of protein kinase C, inhibition with 100 nM 3-[1-[3-(dimethylamino)propyl]-5-methoxy-1H-indol-3-yl]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione (Goe 6983) maintains adequate isoform SERCA2 levels | additional information |